SELLAS Life Sciences Group, Inc.

SLS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Jan 3, 2019 FORM 4 SUBMISSION
SC 13G/A Jan 3, 2019 SABBY 13G-A SLS 1.103.19
3 Dec 19, 2018 FORM 3 SUBMISSION
8-K Dec 18, 2018 8-K
8-K Dec 12, 2018 8-K
8-K Nov 15, 2018 8-K
10-Q Nov 14, 2018 10-Q
8-K Nov 9, 2018 8-K
8-K/A Oct 24, 2018 8-K/A
8-K/A Oct 17, 2018 FORM 8-K/A
SC 13D/A Oct 10, 2018 SC 13D AMENDMENT NO. 3
8-K/A Oct 5, 2018 8-K/A
8-K Oct 2, 2018 8-K
4 Sep 26, 2018 FORM 4 SUBMISSION
10-Q Aug 14, 2018 10-Q
8-K Aug 6, 2018 FORM 8-K
EFFECT Jul 26, 2018
424B3 Jul 26, 2018 424B3
424B3 Jul 26, 2018 424B3
UPLOAD Jul 26, 2018
CORRESP Jul 25, 2018
SC 13G Jul 23, 2018 ACQUISITION OF BENEFICIAL OWNERSHIP
SC 13D/A Jul 23, 2018 SC 13D AMENDMENT NO. 2
8-K Jul 23, 2018 FORM 8-K
SC 13G Jul 23, 2018 JULY 23, 2018
← Newer Page 15 of 51 · 1272 filings Older →